Newsroom
iHealth Manufactures Over 70 Million iHealth COVID-19 Test Kits in Irwindale, CA
iHealth's manufacturing facility for COVID-19 tests in Irwindale, CA has manufactured over 70 million test kits to-date. The iHealth team has made a substantial investment to establish this US-based production facility for COVID-19 at-home tests. The facility, which opened in August 2022, spans 57,800 square feet and boasts 32 production lines. iHealth has created hundreds of local jobs and has production capacity of up to one million tests per day.
Read More
iHealth Launches Home Collection Kit for STD Testing
iHealth launched the CheckMeSafe Home Collection kit, its first in the STD OTC test category, in response to the growing STD crisis in the US. The CDC has called for more groups from local, healthcare industry and public health sectors to contribute to STI prevention and innovation efforts. The FDA-approved CheckMeSafe Home Collection kit delivers reliable results of up to 99.9% sensitivity for HIV and 99.5% for syphilis.
Read More
iHealth Donates 1-Million At-Home Tests to the State of California
iHealth Labs, Inc., one of the major suppliers of at-home COVID tests in the U.S. market, is donating 1 million at-home COVID tests to the State of California. This donation will provide California's residents with much-needed support as another surge in coronavirus infections in the state has led to high demand for early detection.
Read More
iHealth's Super Bowl Debut Highlights Its Commitment to Bring More Tests to More People ASAP
iHealth Labs, Inc. made its Super Bowl debut with in-stadium advertising highlighting its commitment to bring at-home COVID-19 tests to more people as quickly as possible. iHealth's Super Bowl advertising featured LED ribbon takeovers and branded openings on the stadium's video board that ran during the breaks at the end of the first and third quarters on Sunday, Feb. 13 at SoFi Stadium.
Read More
iHealth Statement on the COVID-19 Omicron Variant and Its At-Home Test Kit's Effectiveness
iHealth has been continuously monitoring the COVID-19 variants so the iHealth COVID-19 Antigen Rapid Test is ready to address any significant changes in the epidemic. We are confident that our rapid antigen test continues to detect COVID-19 infection, including infection with the Omicron variant.
Read More
Stop the Spread With iHealth's New COVID-19 Self-Test Kit
iHealth Labs, Inc. announced today the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. This self-test is suitable for individual or group testing anytime, anywhere, and delivers test results in 15 minutes at home. It is authorized and available for purchase at iHealthLabs.com in packages of two test kits.
Read MorePopular Articles
iHealth Covid-19 Antigen Rapid Test Expiration Date Extension
iHealth Unveils Breakthrough 3-in-1 At-Home 15-Minute Antigen Test for COVID-19 and Flu A&B
May 8, 2024
iHealth Labs Named Tech Innovation Company of the Year by the Sunnyvale Chamber of Commerce
March 4, 2024
